Cubist in the News

Showing Media Items: 16 of 8

27 Jan 2014

How To Avert An Antibiotic Apocalypse

Forbes - 1/27/14

Want to protect your kids from drug-resistant bacteria? Open your wallet.

Governments and insurance companies need to commit to paying 10 or 50 times more than they already do if industry is going to put resources into fighting the threat of superbugs.

16 Dec 2013

Cubist Pharma on the Front Lines of Superbug War

NBR - 12/16/13

At Cubist Pharmaceuticals‘ labs in Lexington, Mass., researchers feel like they are in a race against time. They are trying to develop antibiotics to fight infections that are becoming increasingly untreatable and deadly. And they feel they are playing catch up with these superbugs.

16 Dec 2013

Watch the video: Cubist Pharma on the Front Lines of Superbug War

CNBC - 12/16/13

Cubist Pharmaceutical CEO Michael Bonney talks to CNBC's Bertha Coombs about his company's big bet on antibiotics to treat superbugs, which recently drove the firm to acquire two smaller rivals. He leaves the door open to future deals.

22 Oct 2013

Hunting the Nightmare Bacteria: Who’s Trying to Fix the Pipeline Problem?

PBS Frontline - 10/22/13

The problem is clear: There aren’t enough new antibiotics. The question is why aren’t more pharmaceutical companies filling the gap – and what’s being done to try to reverse this trend?

19 Sep 2013

Here’s How One Antibiotics Maker Finds Success

Bloomberg - 9/19/13

Bloomberg’s Olivia Sterns examines drugmaker Cubist and their ability to make a profit in antibiotics as other companies fall short. She speaks on Bloomberg Television’s “In The Loop.”

1 Sep 2013

Addressing the Unmet Need for Anti-Infective Development. Cubist feature in SciBX Collections on Antibiotic Resistance


Rising to the challenge of multidrug-resistant bacteria, Cubist is building a robust anti-infective development portfolio.